Mortality risk with preadmission metformin use in patients with COVID‐19 and diabetes: A meta‐analysis-Reference-Cited by-同舟云学术

Mortality risk with preadmission metformin use in patients with COVID‐19 and diabetes: A meta‐analysis

Published:2020-09-30 Issue:2 Volume:93 Page:695-697
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J Med Virol

Author:

Kow Chia Siang¹,Hasan Syed Shahzad²³^ORCID

Affiliation:

1. School of Postgraduate Studies International Medical University Kuala Lumpur Malaysia

2. Department of Pharmacy University of Huddersfield Huddersfield UK

3. School of Biomedical Sciences & Pharmacy University of Newcastle Callaghan Australia

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.26498

Reference19 articles.

1. Epidemiology of COVID‐19: a systematic review and meta‐analysis of clinical characteristics, risk factors and outcomes [published online ahead of print August 13, 2020];Li J;J Med Virol

2. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020

3. A review on the protective effects of metformin in sepsis‐induced organ failure;Ismail Hassan F;Cell J,2020

4. A proposed mechanism for the possible therapeutic potential of Metformin in COVID-19

5. Metformin in COVID-19: A possible role beyond diabetes

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing existing drugs for the treatment ofCOVID-19/SARS-CoV-2: A review of pharmacological effects and mechanism of action;Heliyon;2024-08

2. Clinical Course and Factors Associated With Hospital Admission and Mortality among Sars-Cov 2 Patients within Nairobi Metropolitan Area;2024-05-15

3. The Effect of Antihyperglycemic Medications on COVID-19: A Meta-analysis and Systematic Review from Observational Studies;Therapeutic Innovation & Regulatory Science;2024-04-29

4. Therapy of Type 2 Diabetes;Experimental and Clinical Endocrinology & Diabetes;2024-04-10

5. Therapie des Typ-2-Diabetes;Die Diabetologie;2024-01-30